Edoxaban versus enoxaparin – warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial - Götte, A; Merino, JL; Ezekowitz, MD (Lancet, 2016)